drugset
Drugs / 14N Sodium Nitrate
last change Dec 2023 re-read 3 minutes ago

14N Sodium Nitrate

Developed for
pulmonary hypertension
Investigated by
Gladwin, Mark, MD · National Heart, Lung, and Blood Institute (NHLBI) · National Institutes of Health (NIH) · University of Pittsburgh

Trials 1

today NCT03787082 · Ph 1
2023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT03787082 Dec 2022 → Dec 2023 diastolic heart failure, pulmonary hypertension Gladwin, Mark, MD Withdrawn No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as 14N Sodium Nitrate “Participants will receive a single dose of the study drug,:14N Sodium Nitrate(1000mg): standard sodium nitrate, and all will receive one dose of CLA 3g.” NCT03787082 ↗
Route Oral “1,000 mg/11.18 mmol, oral” NCT03787082 ↗